First Financial Bankshares’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5M Buy
21,220
+510
+2% +$287K 0.22% 66
2026
Q1
$12.3M Sell
20,710
-324
-2% -$161K 0.25% 65
2025
Q4
$10.2M Buy
21,034
+55
+0.3% +$25.6K 0.21% 64
2025
Q3
$8.79M Buy
20,979
+6,855
+49% +$2.31M 0.18% 66
2025
Q2
$4.06M Buy
14,124
+355
+3% +$106K 0.09% 80
2025
Q1
$4.24M Buy
13,769
+42
+0.3% +$14.4K 0.09% 76
2024
Q4
$4.84M Buy
13,727
+21
+0.2% +$7.72K 0.1% 77
2024
Q3
$4.91M Buy
13,706
+129
+1% +$43.6K 0.1% 77
2024
Q2
$4.32M Buy
13,577
+100
+0.7% +$26.5K 0.1% 76
2024
Q1
$3.1M Buy
13,477
+5,754
+75% +$1.3M 0.07% 85
2023
Q4
$1.7M Buy
+7,723
New +$1.78M 0.04% 98

Other funds holding UTHR

First Financial Bankshares's UTHR Position: Q2 2026 in Review

First Financial Bankshares increased its United Therapeutics (UTHR) stake by 2.5% in Q2 2026, buying an estimated $287K and bringing the position to 21,220 shares worth $11.5M. The position accounts for 0.22% of the portfolio, ranked #66.

First Financial Bankshares first reported a position in UTHR in Q4 2023 and has held it in 11 quarters since. The position peaked at $12.3M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • First Financial Bankshares held 21,220 shares of United Therapeutics worth $11.5M as of Q2 2026.
  • First Financial Bankshares bought 510 United Therapeutics shares in Q2 2026, an estimated $287K.
  • United Therapeutics made up 0.22% of First Financial Bankshares's portfolio in Q2 2026, its #66 holding.
  • First Financial Bankshares first reported a position in United Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • First Financial Bankshares's United Therapeutics position peaked at $12.3M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on First Financial Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.